Press release! We are excited to share that Authera enters into a collaborative agreement with The Jackson Laboratory. Read more about this here: authera.bio/#News @jacksonlab @ShareLabOslo @InnovasjonNorge @forskningsradet @LifeScienceNO

Happy to share that we have entered into a Research Agreement with @argenxglobal to broaden our understanding of FcRn biology. medwatch.no/nyheter/legemidl… @InnovasjonNorge @e24 @forskningsradet @DagensMedisin @MedWatchNews

We recently received support from @Tekna in the form of Harald Boes stipend! The funds will be used to enhance the capacity of our @technology platform. Thank you @Tekna, for this important support to continue to #innovate! @InnovasjonNorge @forskningsradet

It is our pleasure to share that we today received an IPN grant from @forskningsradet! This project will fuel our development pipeline. We are excited to work further with our partners. More to come soon! CuridaDiatec @LifeScienceNO @ShareLabOslo @Oslounivsykehus @TheAbSociety

Read about our recent Innovation Norway grant in @MedWatchNews! We are very excited about this project where we will work with Advokatfirmaet Schjødt and others to expand our capacities. Collaboration is key! medwatch.no/nyheter/legemidl… @LifeScienceNO @InnovasjonNorge

Company update! We have received a grant for commercialization and mentoring services from Innovation Norway. We will use the grant to expand our infrastructure and collaborations. We thank @InnovasjonNorge for making this possible!

Press release! Authera AS is now officially launched. We will work to translate biological insights into innovative design of therapeutic biologics. Read more about our vision, company structure and collaborators here. authera.bio/#News